Alkem Laboratories Ltd had earlier announced about "US FDA Inspection at Alkem' s manufacturing facility located at St. Louis, USA". The Company has now received a letter from the US FDA classifying the inspection conducted at its St. Louis facility as Official Action Indicated (OAI).
St. Louis facility contributes about 2% of the Company's total US revenues or about 0.5% of the Company's consolidated revenues. The Company believes that this classification will not have any significant impact on existing supplies or the existing revenues from the operations of this facility.
The Company shall continue to work closely with US FDA to close out all the observations associated with this inspection.
Shares of Alkem Laboratories Ltd was last trading in BSE at Rs.1707.85 as compared to the previous close of Rs. 1713.95. The total number of shares traded during the day was 287 in over 70 trades.
The stock hit an intraday high of Rs. 1731.4 and intraday low of 1707.85. The net turnover during the day was Rs. 493505.